Yellowfin Tuna recalled in California over high histamine levels

Yellowfin Tuna
Photo illustration

Fresh Catch Inc of Los Angeles, CA is recalling certain Fresh Catch Inc. Yellowfin Tuna because of high histamine levels.

According to the details posted online by the Food and Drugs Administration (FDA), the recall was initiated on June 12, 2024, and is ongoing.

The recalled product was distributed in California.

High levels of histamine can produce an allergic reaction, called histamine fish poisoning or scombroid fish poisoning, that may result in symptoms that generally appear within minutes to an hour after eating the affected fish. 

The most common symptoms of histamine or scombroid fish poisoning are tingling or burning sensation in the mouth, facial swelling, rash, hives and itchy skin, nausea, vomiting or diarrhea; these symptoms usually resolve within several hours without medical intervention. However, each individual may experience symptoms differently; if symptoms are severe an individual may need to seek medical attention for treatment with antihistamines.

Recalled product:

Fresh Catch Inc. Yellowfin Tuna

  • 1 loin per case packaged in cardboard boxes with keep refrigerated label
  • Product Quantity: 716 lbs
  • Code Information: PO# 461079 exp: 04/05/24, PO# 111097 exp: 04/05/24

Consumers should not use this product. Recalled products should be thrown out or returned to their place of purchase.

(To sign up for a free subscription to Food Safety News, click here.)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
TOWARDS MALARIA ELIMINATION: STRENGTHENING THE QUALITY OF MALARIA DIAGNOSTIC SERVICES IN SAO TOME AND PRINCIPE thumbnail

TOWARDS MALARIA ELIMINATION: STRENGTHENING THE QUALITY OF MALARIA DIAGNOSTIC SERVICES IN SAO TOME AND PRINCIPE

External Competency Assessment for Malaria Microscopists (ECAMM) Workshop - 09 to 20 January 2023 Malaria is a preventable, treatable, and curable disease. However, without prompt diagnosis and effective treatment, malaria can progress to a severe form of the disease and death. The WHO African Region carries a disproportionately high share of the global burden of the
Read More
Scientists review early warning tools for food safety thumbnail

Scientists review early warning tools for food safety

A recent review assessed how technology can play a role in early warning and emerging risk identification systems. The review covers the existing applications of artificial intelligence, big data, and internet of things (IoT) in developing early warning and emerging food safety risk identification tools and methods. Information comes from 40 original studies and 57
Read More
Study: Children With Alopecia Areata Respond to Tofacitinib thumbnail

Study: Children With Alopecia Areata Respond to Tofacitinib

Oral tofacitinib (Xeljanz), a JAK inhibitor, helped regrow hair in three quarters of pediatric patients with alopecia areata (AA) in a small study conducted at the University of Colorado and published in Pediatric Dermatology. The 11 pediatric patients, ages 8 to 18 years, all with a diagnosis of AA, were treated with tofacitinib. Eight patients,…
Read More
Rituximab and COVID Shots: Studies Begin to Answer Key Questions thumbnail

Rituximab and COVID Shots: Studies Begin to Answer Key Questions

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Rituximab has presented something of a conundrum for patients taking the monoclonal antibody during the COVID-19 pandemic. Used to manage a variety of autoimmune diseases and cancers, rituximab acts against CD20 proteins expressed on the surface of B cells, causing B-cell…
Read More
Index Of News
Total
0
Share